The effect of amifostine on pathophysiological changes in vasogenic brain edema induced by an experimental cold injury model. 2015

Kemal Cengiz, and Ethem Goksu, and Arzu Cengiz, and Ozlem Ozsoy, and Ruken Tan, and Necdet Demir, and Inanc Gurer, and Saim Kazan
Akdeniz University, School of Medicine, Department of Neurosurgery, Antalya, Turkey.

OBJECTIVE To investigate the effects of amifostine, a cytoprotective agent, on pathophysiological changes in vasogenic brain edema induced by an experimental cold injury model and to compare these changes with dexamethasone. METHODS A total of 138 rats divided into 6 groups. Brain water content (BWC), malondialdehyde (MDA) concentration and myeloperoxidase (MPO) activity in brain tissue were calculated to evaluate the pathophysiological changes following experimental cold injury. In addition, effects of cold injury on cell structure were assessed with direct light and transmission electron microscopy (TEM). RESULTS Extent of edema, MDA and MPO levels were significantly higher in cold injury groups than in controls. Although a decrease was noted in these parameters in both the amifostine and dexamethasone groups, the differences were significant only for MDA concentration in dexamethasone group, and for MPO activity in both groups. In addition, there was a significant difference between the group in which amifostine was administered prior to cold injury and dexamethasone group for MPO activity. Histopathologically, positive effects were observed in treatment groups. CONCLUSIONS Despite several positive effects of amifostine, its superiority to dexamethasone could not be clearly demonstrated. Further experimental and clinical studies are warranted to better delineate the neuroprotective effects of amifostine.

UI MeSH Term Description Entries
D008315 Malondialdehyde The dialdehyde of malonic acid. Malonaldehyde,Propanedial,Malonylaldehyde,Malonyldialdehyde,Sodium Malondialdehyde,Malondialdehyde, Sodium
D009195 Peroxidase A hemeprotein from leukocytes. Deficiency of this enzyme leads to a hereditary disorder coupled with disseminated moniliasis. It catalyzes the conversion of a donor and peroxide to an oxidized donor and water. EC 1.11.1.7. Myeloperoxidase,Hemi-Myeloperoxidase,Hemi Myeloperoxidase
D001929 Brain Edema Increased intracellular or extracellular fluid in brain tissue. Cytotoxic brain edema (swelling due to increased intracellular fluid) is indicative of a disturbance in cell metabolism, and is commonly associated with hypoxic or ischemic injuries (see HYPOXIA, BRAIN). An increase in extracellular fluid may be caused by increased brain capillary permeability (vasogenic edema), an osmotic gradient, local blockages in interstitial fluid pathways, or by obstruction of CSF flow (e.g., obstructive HYDROCEPHALUS). (From Childs Nerv Syst 1992 Sep; 8(6):301-6) Brain Swelling,Cerebral Edema,Cytotoxic Brain Edema,Intracranial Edema,Vasogenic Cerebral Edema,Cerebral Edema, Cytotoxic,Cerebral Edema, Vasogenic,Cytotoxic Cerebral Edema,Vasogenic Brain Edema,Brain Edema, Cytotoxic,Brain Edema, Vasogenic,Brain Swellings,Cerebral Edemas, Vasogenic,Edema, Brain,Edema, Cerebral,Edema, Cytotoxic Brain,Edema, Cytotoxic Cerebral,Edema, Intracranial,Edema, Vasogenic Brain,Edema, Vasogenic Cerebral,Swelling, Brain
D001930 Brain Injuries Acute and chronic (see also BRAIN INJURIES, CHRONIC) injuries to the brain, including the cerebral hemispheres, CEREBELLUM, and BRAIN STEM. Clinical manifestations depend on the nature of injury. Diffuse trauma to the brain is frequently associated with DIFFUSE AXONAL INJURY or COMA, POST-TRAUMATIC. Localized injuries may be associated with NEUROBEHAVIORAL MANIFESTATIONS; HEMIPARESIS, or other focal neurologic deficits. Brain Lacerations,Acute Brain Injuries,Brain Injuries, Acute,Brain Injuries, Focal,Focal Brain Injuries,Injuries, Acute Brain,Injuries, Brain,Acute Brain Injury,Brain Injury,Brain Injury, Acute,Brain Injury, Focal,Brain Laceration,Focal Brain Injury,Injuries, Focal Brain,Injury, Acute Brain,Injury, Brain,Injury, Focal Brain,Laceration, Brain,Lacerations, Brain
D003080 Cold Temperature An absence of warmth or heat or a temperature notably below an accustomed norm. Cold,Cold Temperatures,Temperature, Cold,Temperatures, Cold
D003907 Dexamethasone An anti-inflammatory 9-fluoro-glucocorticoid. Hexadecadrol,Decaject,Decaject-L.A.,Decameth,Decaspray,Dexasone,Dexpak,Hexadrol,Maxidex,Methylfluorprednisolone,Millicorten,Oradexon,Decaject L.A.
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004999 Amifostine A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia. Ethiofos,Gammaphos,APAETP,Amifostine Anhydrous,Amifostine Disodium Salt,Amifostine Monohydrate,Amifostine Monohydrochloride,Amifostine Trihydrate,Aminopropyl Aminoethylthiophosphate,Aminopropylaminoethylthiophosphate,Aminopropylaminoethylthiophosphoric Acid,Ethanethiol, 2-((3-aminopropyl)amino)-, dihydrogen phosphate (ester), trihydrate,Ethiofos Anhydrous,Ethyol,NSC-296961,S-(N-(3-Aminopropyl)-2-aminoethyl)thiophosphoric Acid,WR-2721,YM-08310,NSC 296961,NSC296961,WR 2721,WR2721,YM 08310,YM08310
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

Kemal Cengiz, and Ethem Goksu, and Arzu Cengiz, and Ozlem Ozsoy, and Ruken Tan, and Necdet Demir, and Inanc Gurer, and Saim Kazan
November 2008, Surgical neurology,
Kemal Cengiz, and Ethem Goksu, and Arzu Cengiz, and Ozlem Ozsoy, and Ruken Tan, and Necdet Demir, and Inanc Gurer, and Saim Kazan
January 1990, Advances in neurology,
Kemal Cengiz, and Ethem Goksu, and Arzu Cengiz, and Ozlem Ozsoy, and Ruken Tan, and Necdet Demir, and Inanc Gurer, and Saim Kazan
March 1986, Journal of neurosurgery,
Kemal Cengiz, and Ethem Goksu, and Arzu Cengiz, and Ozlem Ozsoy, and Ruken Tan, and Necdet Demir, and Inanc Gurer, and Saim Kazan
November 1987, Nihon geka hokan. Archiv fur japanische Chirurgie,
Kemal Cengiz, and Ethem Goksu, and Arzu Cengiz, and Ozlem Ozsoy, and Ruken Tan, and Necdet Demir, and Inanc Gurer, and Saim Kazan
May 1997, Journal of neurotrauma,
Kemal Cengiz, and Ethem Goksu, and Arzu Cengiz, and Ozlem Ozsoy, and Ruken Tan, and Necdet Demir, and Inanc Gurer, and Saim Kazan
April 1989, Journal of neurosurgery,
Kemal Cengiz, and Ethem Goksu, and Arzu Cengiz, and Ozlem Ozsoy, and Ruken Tan, and Necdet Demir, and Inanc Gurer, and Saim Kazan
January 2003, Acta neurochirurgica. Supplement,
Kemal Cengiz, and Ethem Goksu, and Arzu Cengiz, and Ozlem Ozsoy, and Ruken Tan, and Necdet Demir, and Inanc Gurer, and Saim Kazan
October 1982, Brain research,
Kemal Cengiz, and Ethem Goksu, and Arzu Cengiz, and Ozlem Ozsoy, and Ruken Tan, and Necdet Demir, and Inanc Gurer, and Saim Kazan
March 1974, Experientia,
Kemal Cengiz, and Ethem Goksu, and Arzu Cengiz, and Ozlem Ozsoy, and Ruken Tan, and Necdet Demir, and Inanc Gurer, and Saim Kazan
June 1952, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
Copied contents to your clipboard!